Go Back To Menu
Close
- Mailing Form
-
Medical Report*
-
Go Back To Menu
Laryngeal cancer is a type of pharyngeal cancer, referring to normal laryngeal cells becoming abnormal and growing uncontrollably. It predominantly occurs in males, with over 180,000 new cases and about 100,000 related deaths annually worldwide. In the United States, approximately 12,650 new cases and 3,880 related deaths occur each year.
For early-stage laryngeal cancer, the goal is cure, using local treatments to improve regional control and survival. In addition, treatment should aim to preserve laryngeal function, including swallowing ability, airway protection, and voice quality. Ideally, outcomes should enhance both laryngeal function and overall survival.
Stage I and Stage II diseases have survival rates of >90% and >80% respectively. Depending on the lesion’s location, glottic laryngeal cancer has the highest 5-year overall survival rate (80%-91%), while supraglottic laryngeal cancer (55%-75%) and subglottic laryngeal cancer (50%-86%) are lower.
Laryngeal cancer has a high incidence worldwide, especially among men. Western countries such as the United States and parts of Europe have higher prevalence, while Southeast Asian countries like Thailand and Vietnam also show an increasing trend. Smoking and alcohol consumption are the main risk factors, affecting hundreds of thousands globally.
1. Impaired Voice Function
Laryngeal cancer often damages the vocal cords, leading to hoarseness or loss of voice, seriously affecting daily communication and quality of life.
2. Risk of Breathing Obstruction
Tumor growth may block the airway, causing breathing difficulties. In severe cases, emergency tracheotomy may be needed to maintain airway patency.
3. Swallowing Difficulties and Malnutrition
Tumor extension near the esophagus may cause swallowing disorders, reducing nutritional intake and endangering life.
4. Decline in Quality of Life
Pain, weight loss, and psychological stress together significantly reduce overall quality of life and willingness to survive.
Immune reconstruction cell therapy activates the patient’s own immune system to effectively identify and eliminate tumor cells, improving treatment outcomes.
During actual treatment, cancer patients often face impaired immunity, increased infection risk, and slow recovery due to surgery, radiotherapy, and chemotherapy. To help patients better withstand treatment, enhance tolerance, and improve quality of life, phased and scientifically tailored immune reconstruction plans are required at different treatment stages.
● Short-term plan: Rapidly boost immunity through immune cell transfusion, enhancing anti-tumor treatment effectiveness.
● Mid-term plan: Reduce side effects of traditional treatments, promote recovery, and ensure completion of standard therapies.
● Long-term plan: Enhance overall immunity through immune cell reconstruction, gut immunity restoration, elemental immunity rebuilding, and immune nutrition reconstruction, thereby improving quality of life and prolonging survival.
1. Surgical Treatment
Surgery is the traditional curative method for laryngeal cancer, suitable for early-stage patients. Minimally invasive laryngoscopic techniques are widely used, reducing tissue damage and allowing faster recovery.
2. Radiation Therapy
Radiotherapy can be used as a curative or adjuvant treatment. Intensity-modulated radiotherapy enables precise targeting of lesions while sparing normal tissues.
3. Chemotherapy
Mainly applied to advanced or inoperable cases, chemotherapy combined with radiotherapy improves local control and reduces distant metastases.
4. Minimally Invasive Treatments
Including laser surgery and endoscopic electrosurgery, these are suitable for early-stage laryngeal cancer, causing minimal trauma, faster recovery, and better functional preservation.
5. Targeted Therapy
By targeting specific molecular pathways, targeted therapy blocks tumor growth signals and improves outcomes when combined with other treatments.
Experts at United Life International Medical Center emphasize that laryngeal cancer treatment requires multidisciplinary collaboration, integrating immune reconstruction cell therapy with modern minimally invasive techniques to achieve precise, personalized treatment. Early detection and timely intervention are crucial for improving prognosis. Patients should actively cooperate with scientific treatment to enhance quality of life.
